Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE/Euronext: DSM KON), today announced the signing of a 3 year master supply agreement with Eisai Inc., based in Woodcliff Lake, NJ,...
read more
DSM, a global leader in materials science and regenerative medicine, announced today the launch of its cellular therapy development services. Cellular therapies use a patient’s own cells to improve healing of an injury or disease. DSM develops ...
read more
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics plant of the future' will open in June 2013.
read more
Thursday, October 31, 2013
Royal DSM, the global Life Sciences and Materials Sciences company, today announced it has signed an agreement with the Sanquin Blood Supply Foundation (Sanquin) for the commercial manufacture of a monoclonal antibody used for the recovery and ...
read more
Wednesday, November 06, 2013
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with Opthea Pty Ltd of Melbourne, Australia.
read more
DSG, Inc., a provider of eClinical technology solutions, data management, professional services and customer support recently opened a new office in Bangalore, India, to accommodate rapid growth and better serve client needs.
read more
DrugDev and Citeline, part of Informa’s Pharma Intelligence vertical, announced the two companies integrated data from Citeline’s Trialtrove and Sitetrove intelligence platforms with the DrugDev Spark unified clinical operations suite.
read more
From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.
read more
Wednesday, January 15, 2025
Dr. Vince Clinical Research (DVCR) announced the expansion of its research campus by constructing a new 5,000-square-foot administration building in Overland Park, Kansas.
read more
Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO), announced the appointment of Sheldon Preskorn, M.D., as its Senior Vice President of Neuroscience.
read more
Dr. Reddy’s Laboratories and CHD Bioscience announced a global licensing agreement for the clinical development and commercialization of Dr. Reddy’s Phase III clinical trial candidate, DFA-02.
read more
Wednesday, February 19, 2020
Dr. Reddy’s Laboratories has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business.
read more
Wednesday, December 20, 2017
The US subsidiary of Dr. Reddy’s has reached a settlement with the US Government involving packaging for five blister-packed prescription products.
read more
Dr. Reddy’s announced the launch of Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended-Release Tablets, USP.
read more
Monday, February 01, 2016
Dr. Reddy's Laboratories has announcedthat the U.S. Food and Drug Administration tentative approval for Zenavod™ (doxycycline) Capsules, 40 mg. Zenavod is a tetracycline-class drug indicated for the treatment of only inflammatory lesions (papules and...
read more